This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Omeprazole | Esomeprazole | |
|---|---|---|
| Active Substances | OMEPRAZOLE | ESOMEPRAZOLE |
| ATC Code | A02BC01 | A02BC01 |
| Form | TABLET, DELAYED RELEASE | CAPSULE, DELAYED RELEASE |
| Dosage | 20 mg/1 | 20 mg/1 |
| Route | ORAL | ORAL |
| Manufacturer | Meijer, Inc. | Dolgencorp Inc |
| Indications | — | This medication is a proton pump inhibitor (PPI), prescribed for gastroesophageal reflux disease (GERD). With amoxicillin and clarithromycin it is used for treatment of Helicobacter pylori infection and duodenal ulcer. It is also used to aid in reduction in occurrence of gastric ulcers associated with continuous NSAID therapy, and in Zollinger-Ellison syndrome. It blocks the production of stomach acid. |
| Side Effects | — | Central Nervous System - Headache, dizziness, drowsiness, aggression, agitation, depression, hallucination. Skin - Itching, hair loss, severe allergic reactions, photosensitivity, blistering. Eye and ENT - Blurred vision. Gastrointestinal - Flatulence, abdominal pain, stomach upset, nausea, diarrhea, dry mouth, constipation, GI fungal infection, inflammation of pancreas and intestine, mouth ulcer, taste disturbance. Genitourinary - Breast enlargement in men, kidney disorder. Liver - Occurrence of confusion, altered level of consciousness and coma as a result of liver failure(Hepatic encephalopathy) , liver failure, inflammation of liver with or without jaundice. Blood - Decrease in white blood cells. Local - Injection-site reactions including mild local redness and itching with IV administration. Musculoskeletal - Muscular weakness, muscle pain. Respiratory - Asthma, respiratory tract infection. Miscellaneous - Severe allergic reaction/shock. |
Omeprazole (INN: OMEPRAZOLE, ATC A02BC01) and Esomeprazole (INN: ESOMEPRAZOLE, ATC A02BC01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
| Warnings | — | •Caution needed for children, pregnancy and breastfeeding women. • It may cause malignancy and liver impairment. While taking this medication, there is an increased risk of developing certain infections such as community-acquired pneumonia. |
|---|